Author

Balaji Veeraragavan

Christian Medical College, Vellore

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Aan RuthiD· 1 shared Aswathy C. SagilkumariD· 1 shared Ayyanraj NeeraviiD· 1 shared Charmi M. Panchal· 1 shared Himani Dhyani· 1 shared Joel AbrahamiD· 1 shared K BHASKARAN· 1 shared Karthik SubramanianiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Aan RuthORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Sorafenib, a clinically approved kinase inhibitor attenuates Streptococcus pneumoniae pathogenesis in vivo by targeting serine/threonine kinase StkP

Joel Abraham, Aswathy C. Sagilkumar, Himani Dhyani, Charmi M. Panchal, Shaheena Aziz, M K Priyadatha, Aan Ruth, K BHASKARAN, Sivakumar Krishnankutty Chandrika, S. Shaima, Rosemol Varghese, Ayyanraj Neeravi, Balaji Veeraragavan, Nagarjun Narayanaswamy, Sandhya Ganesan, Karthik Subramanian

This study shows that sorafenib, a cancer drug, targets StkP in Streptococcus pneumoniae, reducing bacterial pathogenesis and mortality in mice.

mBio · Jun 16, 2026Peer-reviewedMicrobiology